Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
about
CefepimeblaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids.First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United StatesFirst detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.Effects of ceftiofur and chlortetracycline treatment strategies on antimicrobial susceptibility and on tet(A), tet(B), and bla CMY-2 resistance genes among E. coli isolated from the feces of feedlot cattleCommunity acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.Molecular epidemiology of blaCMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific NorthwestImplementation of antibiotic management teams in Belgian hospitals.In vivo acquisition of high-level resistance to imipenem in Escherichia coliRole of ceftiofur in selection and dissemination of blaCMY-2-mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle.Ertapenem resistance of Escherichia coli.AmpC beta-lactamases.AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniaeInfections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa.In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.Impact of treatment strategies on cephalosporin and tetracycline resistance gene quantities in the bovine fecal metagenome.Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008Extended-spectrum beta-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in FranceFirst identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.Distribution of Virulence Factors According to Antibiotic Susceptibility among Escherichia coli Isolated from Urinary Tract Infection.
P2860
Q29040262-B5797400-8D41-4AC8-A2BA-0634A8911F0AQ33613669-6CB13FF2-31AE-41CA-9F03-721E52F165ADQ34045397-5AF3634D-21D1-4D0A-A1DA-D3751088B6DCQ34973735-CF191472-F071-483B-8A07-46A489AB2CF4Q35049123-47AB0103-69EF-41F8-904E-2BF21536F0C0Q35559648-5320D39E-72EF-4B25-BC9E-149562E19C3EQ35917401-F69BA6D8-33A0-4156-A75E-614649794F5BQ36313492-28BCF72C-8A57-4007-806D-E720A605EF31Q36515260-C41E47AE-7483-46CD-BE51-06880653E5F3Q37156252-2CA69CAC-7AF8-4E02-A617-5A2BA1896667Q37204382-3ECDB3AB-865B-49A6-835C-58A9AD82E40EQ37302659-533C3798-9885-44E4-AB7D-8053A3A31DE1Q37366249-3F159115-1484-462D-8EAA-72F95438C619Q37568397-656344CB-CF17-4540-B2BC-D85618C6FBD2Q37576889-8D9885D0-08E1-49D7-86F2-4693CF4718BFQ37598752-F7C04EE5-DECF-496A-AA46-3377BAC9103FQ37624562-EF0293D8-E62F-4631-B523-DBB09ACB5908Q37734137-968643F0-8D12-4C1A-BA6D-51641EDAC689Q37738498-C49D85AB-29BA-4E79-A35F-42815AE2C5B0Q39843388-05906123-F30B-432F-90C9-D7CDF205F259Q40595436-CAF87592-861A-4444-BD96-8491CBAF6A60Q40750806-434E6E95-2260-49C2-83E7-D457626C6B17Q41910163-45F1E686-7C17-4BEF-99D5-9108467B57B3Q42112242-882D5EE7-4017-458D-BDCF-7B2628D0EA18Q42112359-E03BED9A-EAB8-4A61-A6D7-1216417EC289Q42567039-B6D98F4D-7BE6-4946-9BFA-5C9A2FE87BCAQ55362862-91419DC6-4C92-4660-B869-E17E560AF5FB
P2860
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@en
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@nl
type
label
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@en
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@nl
prefLabel
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@en
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@nl
P2093
P2860
P356
P1476
Broad resistance due to plasmi ...... isolates of Escherichia coli.
@en
P2093
P2860
P304
P356
10.1086/340742
P407
P577
2002-06-24T00:00:00Z